Kishin Koh

Kishin Koh

Auto-generated profile, based on publicly available information

Kishin Koh

Department of Neurology, Graduate School of Medical Sciences, University of Yamanashi, Yamanashi, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2019 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
KKKishin Koh
Kishin Koh
HIHiroyuki Ishiura
Hiroyuki Ishiura
HSHaruo Shimazaki
Haruo Shimazaki
MTMichiko Tsutsumiuchi
Michiko Tsutsumiuchi
YIYuta Ichinose
Yuta Ichinose
YTYoshihisa Takiyama
Yoshihisa Takiyama
Background: Alterations of vacuolar protein sorting‐associated protein 13 (VPS13) family members including VPS13A, VPS13B, and VPS13C lead to chorea acanthocytosis, Cohen syndrome, and parkinsonism, respectively. Recently, VPS13D mutations were identified as a cause of VPS13D‐related movement disorders, which show several phenotypes including chorea, dystonia, spastic ataxia, and spastic paraplegia.Methods: We applied whole‐exome analysis for a patient with a complicated form of hereditary spastic paraplegia (HSP) and her unaffected parents. Then, we screened the candidate genes in 664 Japanese families with HSP in Japan.Results: We first found a compound heterozygote VPS13D mutation and a heterozygote ABHD4 variation in a sporadic patient with spastic paraplegia. Then, we found three patients with VPS13D mutations in two Japanese HSP families. The three patients with homozygous mutations (p.Thr1118Met/p.Thr1118Met and p.Thr2945Ala/p.Thr2945Ala) in the VPS13D showed an adult onset pure form of HSP. Meanwhile, the patient with a compound heterozygous mutation (p.Ser405Arg/p.Arg3141Ter) in the VPS13D showed a childhood onset complicated form of HSP associated with cerebellar ataxia, cervical dystonia, cataracts, and chorioretinal dystrophy.Conclusion: In the present study, we found four patients in three Japanese families with novel VPS13D mutations, which may broaden the clinical and genetic findings for VPS13D‐related disorders.

5 October 2020 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
YOYasuko Odake
Yasuko Odake
KKKishin Koh
Kishin Koh
YTYoshihisa Takiyama
Yoshihisa Takiyama
HIHiroyuki Ishiura
Hiroyuki Ishiura
STShoji Tsuji
Shoji Tsuji
MYMitsuhiro Yoshita
Mitsuhiro Yoshita
Objective To establish molecular diagnosis for a family with a complicated form of autosomal recessive hereditary spastic paraplegia with intellectual disability, cognitive decline, psychosis, peripheral neuropathy, upward gaze palsy, and thin corpus callosum (TCC). Methods Physical examinations, laboratory tests, structural neuroimaging studies, and exome sequence analysis were carried out. Results The 3 patients exhibited intellectual disability and progressive intellectual decline accompanied by psychiatric symptoms. Gait difficulty with spasticity and pyramidal weakness appeared at the ages of 20s–30s. Brain MRI revealed TCC with atrophic changes in the frontotemporal lobes, caudate nuclei, and cerebellum. Exome sequence analysis revealed a novel homozygous c.2654C>A (p. Ala885Asp) variant in the ATP13A2, a gene responsible for a complicated form of hereditary spastic paraplegia (SPG78), Kufor-Rakeb syndrome, and neuronal ceroid lipofuscinosis. The predominant clinical presentations of the patients include progressive intellectual disability and gait difficulty with spasticity and pyramidal weakness, consistent with the diagnosis of SPG78. Of note, prominent psychiatric symptoms and extrapyramidal signs including rigidity, dystonia, and involuntary movements preceded the spastic paraparesis. Conclusions Our study further broadens the clinical spectrum associated with ATP13A2 mutations.

1 January 2019 in Epilepsy & Behavior Case Reports
Verified
Journal Article
Open access
KSKazumasa Shindo
Kazumasa Shindo
MTMai Tsuchiya
Mai Tsuchiya
THTakanori Hata
Takanori Hata
YIYuta Ichinose
Yuta Ichinose
KKKishin Koh
Kishin Koh
YTYoshihisa Takiyama
Yoshihisa Takiyama
We report a case of neuronal intranuclear inclusion disease (NIID) confirmed by detection of intranuclear inclusions in a skin biopsy specimen. Brain magnetic resonance imaging showed mild cerebral atrophy and linear hyperintensities at the corticomedullary junction on diffusion-weighted images. This patient developed nonconvulsive status epilepticus with generalized periodic discharges on electroencephalography after recurrent symptoms of paroxysmal nausea and slowly progressive cognitive decline. There have been no previous reports of NIID with nonconvulsive status epilepticus to our knowledge. Since adult patients with NIID display a wide variety of clinical manifestations, skin biopsy should be considered in patients who have leukoencephalopathy of unknown origin.

27 July 2022 in Human Genome Variation
Verified
Journal Article
Open access
PDF file
KKKishin Koh
Kishin Koh
HSHaruo Shimazaki
Haruo Shimazaki
MOMatsuo Ogawa
Matsuo Ogawa
YTYoshihisa Takiyama
Yoshihisa Takiyama
A heterozygous mutation in GRID2 that causes SCAR18 was first reported in an Algerian family with autosomal dominant cerebellar ataxia (ADCA). We identified the second ADCA family with a heterozygous GRID2 mutation. The Algerian family had cognitive impairment and hearing loss associated with cerebellar ataxia. However, the Japanese family presented here showed pure cerebellar ataxia. Therefore, we should also screen for the GRID2 mutation in ADCA families with pure cerebellar ataxia.

22 June 2022 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
MAMasahiro Ando
Masahiro Ando
YHYujiro Higuchi
Yujiro Higuchi
JYJunhui Yuan
Junhui Yuan
AYAkiko Yoshimura
Akiko Yoshimura
TTTakaki Taniguchi
Takaki Taniguchi
HTHiroshi Takashima
Hiroshi Takashima
Background: Recessive mutations in SLC12A6 have been linked to hereditary motor sensory neuropathy with agenesis of the corpus callosum. Patients with early‐onset peripheral neuropathy associated with SLC12A6 heterozygous variants were reported in 2016. Only five families and three variants have been reported to date, and the spectrum is unclear. Here, we aim to describe the clinical and mutation spectra of SLC12A6‐related Charcot–Marie–Tooth (CMT) disease in Japanese patients.Methods: We extracted SLC12A6 variants from our DNA microarray and targeted resequencing data obtained from 2598 patients with clinically suspected CMT who were referred to our genetic laboratory by neurological or neuropediatric departments across Japan. And we summarized the clinical and genetic features of these patients.Results: In seven unrelated families, we identified one previously reported and three novel likely pathogenic SLC12A6 heterozygous variants, as well as two variants of uncertain significance. The mean age of onset for these patients was 17.5 ± 16.1 years. Regarding electrophysiology, the median motor nerve conduction velocity was 39.6 ± 9.5 m/sec. For the first time, we observed intellectual disability in three patients. One patient developed epilepsy, and her brain MRI revealed frontal and temporal lobe atrophy without changes in white matter and corpus callosum.Conclusions: Screening for the SLC12A6 gene should be considered in patients with CMT, particularly those with central nervous system lesions, such as cognitive impairment and epilepsy, regardless of the CMT subtype.

6 September 2021 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
KKKishin Koh
Kishin Koh
MTMai Tsuchiya
Mai Tsuchiya
HIHiroyuki Ishiura
Hiroyuki Ishiura
HSHaruo Shimazaki
Haruo Shimazaki
TNTakeshi Nakamura
Takeshi Nakamura
JCJapan Spastic Paraplegia Research Consortium
Japan Spastic Paraplegia Research Consortium